Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP [Phase 2]
A Phase 2 clinical trial update for asciminib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia in chroni…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany
A clinical trial update on Asciminib for Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Germany, focusing on …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia [Phase 1]
Phase I clinical trial update for decitabine, lisaftoclax, and olverembatinib in advanced chronic myeloid leukemia and Philadelphia chromoso…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator [Phase 4]
Phase 4 trial extension allowing access to imatinib for patients currently on imatinib in a Novartis-sponsored study who are judged by inves…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib. [Phase 2]
Open-label phase 2 trial of asciminib for chronic myeloid leukemia in chronic or accelerated phase with the T315I mutation who are resistant…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Asciminib RMP Study
Update on Asciminib's risk management plan study for chronic myeloid leukemia; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: ASCiminib, With or Without Dasatinib Combination, as a 2nd-Line Therapy to ADVANCE the Treatment for Chronic Myelogenous Leukemia in Chronic Phase (ASC2ADVANCE) [Phase 2]
A Phase 2 clinical trial evaluating asciminib, alone or in combination with dasatinib, as second-line therapy for chronic myeloid leukemia i…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT [Phase 1]
Stanford is conducting a Phase 1 study evaluating cessation of tacrolimus immunosuppression after allogeneic hematopoietic cell transplantat…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase [Phase 2]
A Phase II clinical trial evaluating olverembatinib as monotherapy for newly diagnosed chronic phase chronic myeloid leukemia; the study is …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
A chart-review study by MD Anderson Cancer Center investigates outcomes of Chronic Myeloid Leukemia patients who were treated with imatinib …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous Treatments
Expanded access update for vodobatinib in patients with Philadelphia chromosome-positive chronic myeloid leukemia who have not responded to …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
Pfizer is recruiting adults with chronic myeloid leukemia for a clinical trial of Bosulif (bosutinib) to study its safety and potential effi…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy [Phase 1]
Phase 1 clinical trial sponsored by the University of Alabama at Birmingham evaluating UAB 2419-CD34 selection using the CliniMACS Prodigy s…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Prospective collection, storage, and reporting of data on patients undergoing hematopoietic stem cell transplantation using a standard prepa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A multicenter protocol to improve access and distribution of unlicensed cryopreserved cord blood units, with the study currently recruiting.…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia [NA]
The ENERGIA study tests a personalized exercise program to reduce fatigue in patients with myeloproliferative neoplasms and chronic myeloid …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft [Phase 1]
A Stanford-sponsored Phase 1 trial is evaluating reduced-intensity, allogeneic hematopoietic cell transplantation with a T-cell–depleted gra…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 study evaluating pembrolizumab in combination with dasatinib, imatinib, or nilotinib for p…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China
A real-world study in China is evaluating how Scemblix (asciminib) is used to treat chronic myeloid leukemia in the chronic phase and is cur…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia [Phase 1]
A Phase 1a/1b study of ELVN-001 for chronic myeloid leukemia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
This clinical trial describes a study of patient characteristics, co-morbidities, and treatment patterns in chronic-phase chronic myeloid le…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant [Phase 1]
Phase 1 clinical trial evaluating CMV-MVA Triplex Vaccine to enhance CMV-specific immunity and prevent CMV viremia in patients undergoing ha…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide [Phase 1]
Phase 1 clinical trial update evaluating expanded/activated gamma delta T-cell infusion after hematopoietic stem cell transplantation with p…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients [Phase 3]
A clinical trial update indicating that Shenzhen TargetRx's investigational drug TGRX-678 is planned for a Phase 3 study in Chinese patients…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase [Phase 2]
A Phase 2 clinical trial evaluating asciminib as initial therapy for adults with chronic-phase chronic myeloid leukemia is currently recruit…